Literature DB >> 12675169

Hepatitis C update.

Shimian Zou1, Leslie Forrester, Antonio Giulivi.   

Abstract

Mesh：

Year:  2003        PMID： 12675169      PMCID： PMC6979800     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN： 0008-4263


× No keyword cloud information.
  24 in total

Review 1.  Hepatitis C--prevention and control: a public health consensus. Ottawa, Canada, October 14-16, 1998.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1999

2.  Nosocomial outbreak of multiple bloodborne viral infections.

Authors:  S Yerly; R Quadri; F Negro; K P Barbe; J J Cheseaux; P Burgisser; C A Siegrist; L Perrin
Journal:  J Infect Dis       Date:  2001-07-10       Impact factor: 5.226

3.  Effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde for decreasing risk of transmission of hepatitis C virus.

Authors:  N Sakai; M Tatsuta; H Iishi; H Yano; S Osaka; A Aoki
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

4.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

5.  A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization.

Authors:  M Korenaga; K Hino; Y Katoh; Y Yamaguchi; M Okuda; K Yoshioka; K Okita
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

Review 6.  Preventing the spread of hepatitis B and C viruses: where are germicides relevant?

Authors:  S A Sattar; J Tetro; V S Springthorpe; A Giulivi
Journal:  Am J Infect Control       Date:  2001-06       Impact factor: 2.918

7.  Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers.

Authors:  A E Yeo; M Ghany; C Conry-Cantilena; J C Melpolder; D E Kleiner; J W Shih; J H Hoofnagle; H J Alter
Journal:  J Viral Hepat       Date:  2001-07       Impact factor: 3.728

8.  The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.

Authors:  S Barrett; J Goh; B Coughlan; E Ryan; S Stewart; A Cockram; J C O'Keane; J Crowe
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

Review 9.  Novel cell culture systems for the hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  Antiviral Res       Date:  2001-10       Impact factor: 5.970

10.  Trends of hepatitis B and hepatitis C mortality in Canada, 1979-1997.

Authors:  G Pohani; S Zou; M Tepper
Journal:  Can J Public Health       Date:  2001 Jul-Aug
View more
  6 in total

1.  Building on the Resilience of Aboriginal People in Risk Reduction Initiatives Targeting Sexually Transmitted Infections and Blood-Borne Viruses: The Aboriginal Community Resilience to AIDS (ACRA).

Authors:  Neil Andersson; Bev Shea; Chris Archibald; Tom Wong; Kevin Barlow; Georges Sioui
Journal:  Pimatisiwin       Date:  2008

2.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

3.  Identification of acute vaccine-preventable hepatitis in individuals with chronic hepatitis in British Columbia between 1991 and 2007.

Authors:  Lily Fang; Amanda Yu; Jane A Buxton
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

4.  Feasibility and outcome of HCV treatment in a Canadian federal prison population.

Authors:  John Farley; Shawn Vasdev; Benedikt Fischer; Emma Haydon; Jürgen Rehm; Theresa A Farley
Journal:  Am J Public Health       Date:  2005-08-30       Impact factor: 9.308

Review 5.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

6.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.